Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
2
BCYC Quote, Financials, Valuation and Earnings
Last price:
$14.35
Seasonality move
:
10.25%
Day range:
$14.64 - $15.30
52-week range:
$12.17 - $28.67
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
20.49x
P/B ratio:
1.22x
Volume:
346.4K
Avg. volume:
747.4K
1-year change:
-18.81%
Market cap:
$1B
Revenue:
$27M
EPS (TTM):
-$3.29
Earnings Data
Next earnings date for BCYC
Feb 20
2025
Most recent earnings per share
-$0.74
Beat by $0.04
(Oct 31/2024)
Consensus Estimate
-$0.78
(Oct 31/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BCYC Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/20/2025 | Q4 | $5.3M | -- | -- | -$0.86 | -- |
| 10/31/2024 | Q3 | $7M | $2.7M | -$0.74 | -$0.78 | $0.04 |
| 08/06/2024 | Q2 | $6.3M | $9.4M | -$0.77 | -$1.11 | $0.34 |
| 05/02/2024 | Q1 | $6.1M | $19.5M | -$0.62 | -$1.21 | $0.59 |
| 02/20/2024 | Q4 | $7M | $5.3M | -$1.16 | -$1.19 | $0.03 |
| 11/02/2023 | Q3 | -- | -- | -$1.26 | -$1.06 | -$0.20 |
| 08/03/2023 | Q2 | -- | -- | -$1.41 | -$1.07 | -$0.34 |
| 05/04/2023 | Q1 | -- | -- | -$1.30 | -$0.96 | -$0.34 |
| 02/28/2023 | Q4 | -- | -- | -$1.01 | -$1.04 | $0.03 |
| 11/03/2022 | Q3 | -- | -- | -$0.96 | -$0.91 | -$0.05 |
| 08/04/2022 | Q2 | -- | -- | -$0.90 | -$0.81 | -$0.09 |
| 05/05/2022 | Q1 | -- | -- | -$0.93 | -$0.73 | -$0.21 |
| 03/01/2022 | Q4 | -- | -- | -$0.63 | -$0.59 | -$0.04 |
| 11/04/2021 | Q3 | -- | -- | -$0.59 | -$0.63 | $0.04 |
| 08/05/2021 | Q2 | -- | -- | -$0.74 | -$0.67 | -$0.07 |
| 05/06/2021 | Q1 | -- | -- | -$0.73 | -$0.71 | -$0.02 |
| 03/11/2021 | Q4 | -- | -- | -$0.83 | -$0.41 | -$0.42 |
| 11/05/2020 | Q3 | -- | -- | -$0.52 | -$0.53 | $0.01 |
| 08/05/2020 | Q2 | -- | -- | -$0.67 | -$0.46 | -$0.21 |
| 05/07/2020 | Q1 | -- | -- | -$0.63 | -$0.38 | -$0.25 |
| 03/10/2020 | Q4 | -- | -- | -$0.25 | -$0.52 | $0.27 |
| 11/07/2019 | Q3 | -- | -- | -$0.53 | -$0.70 | $0.17 |
| 08/08/2019 | Q2 | -- | -- | -$1.40 | -$0.62 | -$0.78 |
| 03/31/2019 | Q1 | -- | -- | -$0.37 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.50 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$0.58 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$0.37 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.19 | -- | -- |
Bicycle Therapeutics PLC Earnings Questions
-
How Much did Bicycle Therapeutics PLC Generate in Revenue Last Quarter?
Bicycle Therapeutics PLC reported $2.7M worth of top line sales in its most recent quarter.
-
Did Bicycle Therapeutics PLC Beat Earnings Last Quarter?
Bicycle Therapeutics PLC announced earnings per share of -$0.74 which represents a beat of analyst forecast a -$0.78 per share.
-
Is Bicycle Therapeutics PLC Profitable?
Bicycle Therapeutics PLC reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Bicycle Therapeutics PLC EPS Next Year?
Bicycle Therapeutics PLC's earnings are forecast to decrease from -$5.08 per share to -$5.18 per share next year representing a decrease of -38.77%.
-
When is Bicycle Therapeutics PLC's Earnings Date?
Bicycle Therapeutics PLC's next earnings date is February 20, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 0.73% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 6.88% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.35% over the past day.
